학술논문

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: V enous thromboembolism prophyl A xis after gyneco L ogical p E lvic cancer surgery with RI varoxaban versus enox A parin (VALERIA trial).
Document Type
Article
Source
Clinical & Applied Thrombosis/Hemostasis; Jan-Dec2022, Vol. 28, p1-9, 9p
Subject
ONCOLOGIC surgery
ENOXAPARIN
RIVAROXABAN
LOW-molecular-weight heparin
ORAL medication
Language
ISSN
10760296
Abstract
Copyright of Clinical & Applied Thrombosis/Hemostasis is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)